Terminated PHASE4 INTERVENTIONAL NCT00189072

Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition

Effects of Pain and the Treatment of Pain With Gabapentin (900-3600 Mg) on Driving Ability, Attentional Capacity and Psychomotor Performance in Chronic Neuropathic Pain Patients

Sponsor: UMC Utrecht

Conditions Chronic Neuropathic Pain

Interventions gabapentin

Updated 4 times since 2017 Last updated: Sep 12, 2005 Started: Apr 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from UMC Utrecht

See all terminations from UMC Utrecht

Other Chronic Neuropathic Pain trials with similar outcome

Browse all Chronic Neuropathic Pain trials

This PHASE4 trial investigates Chronic Neuropathic Pain and is currently terminated or withdrawn. UMC Utrecht leads this study, which shows 4 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2017 — Jan 2021 [monthly]

Terminated PHASE4

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

UMC Utrecht
Utrecht University

Data source: UMC Utrecht

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Utrecht, Netherlands